The Technical University of Denmark (DTU) leads the work package, which aims to develop novel ingestible devices that can deliver therapeutic agents with high precision and efficiency within the gastrointestinal (GI) tract. The objectives include enhancing GI retention, targeting specific disease sites, and optimising drug bioavailability through innovative delivery mechanisms and materials.
DC1, DC2, and DC3 are associated with WP1. Their projects focus on micro-sized particle and needle fabrication (DC1), mucoadhesive patches for intestinal drug delivery (DC2), and hydrogel-based kirigami/origami approaches to oral drug delivery (DC3).
Scientific and technical activities include designing and fabricating micro- and nano-scale components, developing advanced mucoadhesive systems, and investigating kirigami/origami approaches. These technologies are intended to work reliably within the complex environment of the GI tract, enabling controlled and sustained drug release.
The anticipated impact of WP1 includes improved patient outcomes through more effective, non-invasive therapies, reduced systemic side effects, and the establishment of new platforms for oral delivery of biologics and precision medicine.